Beckman Selects Fisher Unit, Cellomics, to Provide Ongoing Service for HCS Customers
News Jun 14, 2006
This agreement covers the Beckman Coulter Cell Lab IC 100 Image Cytometer and the EIDAQ 100 High-Throughput Microscopy System.
Beckman Coulter recently announced that it would no longer market these products but would continue to support existing customers.
"Our primary goal in reaching this agreement was to provide ongoing support for our customers," said Karen Bezold, director of Research Cytometry, Beckman Coulter, Inc.
"With Cellomics’ expertise in the HCS field, we are confident our customers will have the best possible support going forward."
Beckman Coulter will continue to focus its research cytometry business on flow cytometry and particle characterization.
"Our agreement with Beckman Coulter is an affirmation of Cellomics’ technology leadership and service excellence," said Ron Lowy, president and chief executive officer of Fisher Biosciences.
"We have the expertise to answer virtually any question concerning HCS and help customers solve any technical problems they may encounter."
"We are excited about the opportunity to serve another group of customers who are interested in HCS technology."
Schizophrenics' Blood Contains RNA From More MicrobesNews
The blood of schizophrenia patients features genetic material from more types of microorganisms than that of people without the debilitating mental illness, research at Oregon State University has found. What’s not known is whether that’s a cause or effect of the severe, chronic condition that strikes about one person in 100.READ MORE
Faulty Gene Leads to Alcohol-Induced Heart FailureNews
A faulty gene interacts with alcohol to accelerate heart failure in susceptible patients, a study suggests. This dangerous interaction can occur even when only moderate amounts of alcohol have been consumed.READ MORE
Bicycle Therapeutics Expands Strategic Partnership with AstraZenecaNews
New programs added in respiratory and cardio-metabolic diseases.READ MORE
Comments | 0 ADD COMMENT
2nd Annual Artificial Intelligence in Drug Development Congress
Sep 20 - Sep 21, 2018